Company Search:
Advanced Search
Sponsored Links
10X Genomics Inc Company Snapshot
10X Genomics Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares 10X Genomics Inc with three other companies in this sector in UNITED STATES : ANI Pharmaceuticals Inc (2019 sales of $206.55 million of which 100% was Pharmaceutical Products), Halozyme Therapeutics, Inc. ($195.99 million of which 36% was Royalties), and Repligen Corporation ($270.25 million of which 100% was Therapeutic Products).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
10X Genomics Inc
  Stock Performance Chart for 10X Genomics Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 142.27
(Figures in U.S. Dollars)
1 Week -13.1%   13 Weeks 14.5%  
4 Weeks 50.3%   52 Weeks 171.0%  
10X Genomics Inc Key Data:
  Ticker: TXG Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 245,893,000
(Year Ending Jan 2020).
Employees: 584
  Currency: U.S. Dollars Market Cap: 14,278,059,280
  Fiscal Yr Ends: December Shares Outstanding: 100,358,890
  Share Type: Common Closely Held Shares: 54,722,427
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.